Compare Lemonade Inc (LMND) vs Symbotic Inc (SYM) Price & Performance

LMND trades at $46.64, down 0.41% on the day, with a bearish technical signal despite recent earnings beats. Revenue growth remains strong at 32% year-over-year in Q2 2026, with improving loss ratios and gross profit up 76%. The company is expanding geographically and expects its first EBITDA-positive quarter in late 2026, supported by AI-driven efficiency gains.

While LMND shows promising growth and path to profitability, the stock faces headwinds from persistent net losses, high valuation multiples, and mixed analyst sentiment. The consensus price target of $67.00 suggests 44% upside potential, but investors must weigh growth prospects against ongoing cash burn and competitive pressures in the insurtech space.

SYM trades at $42.56, down 1.73% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $16.94 million in 2025, though revenue grew to $2.25 billion. Analysts maintain a consensus Buy rating with a $60.33 price target, citing a robust $22.5 billion backlog and positioning in warehouse automation.

The outlook hinges on execution of its large backlog and diversification beyond key customer Walmart. Near-term risks include recent earnings misses and high valuation multiples relative to current profitability. The stock offers growth potential if margin expansion and recurring revenue targets are met, but faces volatility from execution risks and market sentiment.